Scott A. Shell, Ph.D., is an experienced oncology biomarker scientist currently serving as the Director of Scientific Affairs at SAGA Diagnostics. With a Ph.D. in Molecular Biology & Immunology from the University of Pittsburgh School of Medicine, Scott has a robust background working in the pharmaceutical lab services and molecular diagnostic industries. Previously, Scott held senior roles at Guardant Health, IQVIA, and Asuragen, where they developed strong collaborative relationships in the biopharma sector and contributed to the advancement of novel diagnostic technologies. Passionate about improving health outcomes for cancer patients, Scott excels in executing complex studies and delivering scientific presentations to diverse audiences.
This person is not in any teams
This person is not in any offices